Newsletter | May 27, 2025

05.27.25 -- AI Vs. Humans In Novel Drug Target Identification

FEATURED EDITORIAL

AI Vs. Humans In Novel Drug Target Identification

Artificial intelligence is beginning to replace humans in drug discovery, one expert warns — but the industry isn’t ready for the shift.

INDUSTRY INSIGHTS

Dual Antagonistic Anti-LILRB2/LILRB4 Monoclonal Antibody

Discover how our dual LILRB2/LILRB4 antagonist monoclonal antibody offers a promising strategy to target MDSCs and enhance cancer immunotherapy.

Advancing Cell Therapies With Lipid Nanoparticles

Cell therapies offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.

Two Steps Forward, One Step Back: IND Submission In Early Development

A panel of product development experts examines blind spots that can plague early development strategies, as well as important considerations when navigating the path toward an IND submission.

Early Solid Form Screening To Guide Drug Development

Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.

Lung Cancer Treatment By Inhaled Formulations

Explore the formulation and manufacturing of a topotecan inhaled dry powder and its use in decreasing tumor size in an animal model.

MOST POPULAR NEWS

Viva Biotech Launches The AI-Driven Drug Discovery Platform

Rani Therapeutics Announces Research Agreement With Chugai

PharmAla Biotech Launches Phenesafe AI Drug Discovery Platform

Honorhealth Research Institute Patient With Advanced Skin Cancer In Remission

Pfizer Enters Into Exclusive Licensing Agreement With 3SBio

Scientists Discover Potential New Targets For Alzheimer's Drugs

Avenzo Therapeutics Announces FDA Clearance Of IND Application For AVZO-023

Genetic Mutations In Potassium Ion Channel Target Of New Drug Development

Sanofi To Acquire Vigil Neuroscience, Inc

Quantum Biopharma Signs Agreement With A Global Pharmaceutical Contract Research Org

Candidate Drug That Boosts Protective Brain Protein In Mice Has Potential To Treat Alzheimer's

SOLUTIONS

Fragment Screening: Save Time And Sample With Spectral Shift Technology

Boost Your Vaccine Platform With A Monoclonal Suspension